Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 5.7B | 5.2B | 5.0B | 4.3B |
Cost of revenue | 2.7B | 2.4B | 2.4B | 2.1B |
Gross profit | 3.0B | 2.9B | 2.6B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.0B | 1.8B | 1.8B | 1.5B |
Other operating expenses | 351M | 293M | 214M | 307M |
Operating income | 664M | 766M | 623M | 424M |
Non operating interest income | ||||
Income | 7M | 8M | 5M | 2M |
Expense | 65M | 54M | 48M | 46M |
Other income expense | — | — | — | — |
Pretax income | 595M | 724M | 550M | 382M |
Tax provision | 145M | 147M | 107M | 105M |
Net income | 450M | 577M | 443M | 277M |
Basic EPS | — | 312.1 | 239.3 | 148.8 |
Diluted EPS | — | 312.0 | 239.3 | 148.8 |
Basic average shares | — | 7.9M | 7.9M | 7.9M |
Diluted average shares | — | 7.9M | 7.9M | 7.9M |
EBITDA | 1.1B | 1.2B | 1.0B | 816M |
Net income from continuing op. | 595M | 724M | 550M | 382M |
Minority interests | -2M | 2M | 1M | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |